drugset / Trial / NCT00668057

BAY38-9456 (Vardenafil HCL Tablet) in ED Treatment for China Registration.

NCT00668057

Phase 3 Completed 624 enrolled Bayer
RandomizedParallel-groupDouble-blindTreatment

Summary

This study was to compare the efficacy of 3 doses of vardenafil, 5 mg, 10 mg and 20 mg, with matching placebo in Chinese male ED patients, treated for a maximum of 12 weeks.

Timeline

Start
2002-12
Primary completion
2003-09
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Vardenafil Small molecule 5 mg Oral
Subject Vardenafil Small molecule 10 mg Oral
Subject Vardenafil Small molecule 20 mg Oral

Indications